Status:
COMPLETED
Chronotherapy in Inflammatory Bowel Disease
Lead Sponsor:
Rush University Medical Center
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study aims to determine if there is any difference in the efficacy of Inflammatory Bowel Disease (IBD) medication and disease outcomes when taken in the morning or in the evening. The IBD medicat...
Detailed Description
The objective of this study is to determine whether the timing of drug administration to treat inflammatory bowel disease (IBD) has an effect on patient outcomes. Primary objective: Determine whether ...
Eligibility Criteria
Inclusion
- Above the ages of 18
- Diagnosis of Crohn's Disease or Ulcerative Colitis
- Currently taking azathioprine or 6-mercaptopurine
- Willing to sign study consent form
Exclusion
- Vulnerable population (pregnant, prisoner, non-English speaking or cognitively impaired)
- Breastfeeding subject
- Have a history of complications related to immunomodulatory therapy
- Participating in other research studies involving research interventions
- Treated with dual corticosteroid and immunomodulatory therapy
Key Trial Info
Start Date :
April 25 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04304950
Start Date
April 25 2016
End Date
April 1 2023
Last Update
June 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612